New Clinical Research Accreditation Launches

The Global Clinical Site Accreditation (GCSA) has launched with a commitment to increase clinical research and trial capacity and quality in the UK as well as Globally. This will be achieved through the introduction of a leading standard for improving, maintaining and accrediting clinical research sites to improve sponsor and patient experience and increase clinical trials.

The Global Clinical Site Accreditation (GCSA) has launched with a commitment to increase clinical research and trial capacity and quality in the UK as well as Globally. This will be achieved through the introduction of a leading standard for improving, maintaining and accrediting clinical research sites to improve sponsor and patient experience and increase clinical trials.

Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!

With no clear, established standards there remains a broad variance in the operations of clinical research sites across the industry. Sites need to be ready to meet the expectations of the industry and be able to demonstrate this to sponsors. GCSA sets this industry standard for research sites to strive for and achieve; allowing sites to evidence and communicate their capabilities and differentiate in a crowded and increasingly competitive marketplace. Beyond the assessment and accreditation process, where required GCSA will deliver individual, practical support on the areas for development to meet the standards and will work collaboratively with sites to achieve accreditation.

“The need for a globally recognized standard for clinical research sites is stronger than ever with the spotlight now clearly focused on the industry. The more efficiently and competently a research site operates the more high-quality research can be conducted. GCSA is a gamechanger because it offers a practical solution to the industry-wide issues of consistency, safety and pace,” said Angela O’Connell, GCSA chief executive officer. “GCSA provides a clear, informed market-leading standard and supports sites in achieving this standard by providing a pathway to attainment. Most importantly, it facilitates better relationships between sites, patients and sponsors and develops industry collaboration through a network of clinical research stakeholders to ensure continued best practice sharing to deliver industry-leading sites.”

  • <<
  • >>

Join the Discussion